BY OUR PLATFORMS
BY THERAPEUTIC AREA
BY RESEARCH STAGE
01 December 2018 - 31 May 2021
The concept of the InnoTCM project is to apply an innovative approach of profiling the TCM herb extracts by using Zebrafish as a model organism in High Throughput Screening (HTS) manner.
26 November 2018
Valeria Di Giacomo, Senior R&D Researcher in ZeClinics, presents a new paper in collaboration with Qatar University.
06 September 2018 - 24 May 2021
We aim to implement cardiac injury models in zebrafish and to use them to identify genes involved in heart regeneration, with a focus on genes impairing cardiomyocyte dedifferentiation/proliferation.
06 April 2018
The team led by Dr. Morales has synthesized alkylated resveratrol prodrugs to improve antioxidant and anti-inflammatory properties.
01 April 2018 - 31 March 2021
ZF-Glioma's aim was to model human glioma (brain cancer) in zebrafish to screen for tyrosine kinase inhibitors (TKIs) with the potential to treat this devastating disease.
20 March 2018
They explore the benefits of CRISPR/Cas9 to establish innovative zebrafish models to enhance knowledge of the visual cycle.
19 March 2018
07 March 2018
They establish a mechanism that may represent a general principle for neural network assembly in vertebrate species and across different brain areas.
08 February 2018
An Attractive Reelin Gradient Establishes Synaptic Lamination in the Vertebrate Visual System.
19 April 2017
Our article "ZeGlobalTox: An Innovative Approach to Address Organ Drug Toxicity Using Zebrafish" has been published in IJMS
01 April 2017 - 31 March 2019
Within this project ZeClinics developed ZeCardio®, a unique, fully automated, robotic and software-driven cardiovascular screening platform.
01 January 2017 - 31 December 2017
The objective of the project is to analyze libraries of molecules provided by collaborating entities with a view to discovering molecules with cardioprotective and anti-tumor therapeutic actions.
30 July 2015 - 30 July 2018
The STEM-ZeOncoTest is an innovative and versatile product for oncological diagnosis that offers a quick and economical solution for making decisions about the treatment of therapy.
01 June 2015 - 30 June 2017
ZeGlobalTox is an innovative safety test able to reduce the number of used animals, experimental time and R&D costs during drug discovery.
Please leave your details in the form below.